Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
Tibet Rhodiola Pharmaceutical Holding Co
Cash from Investing Activities
Tibet Rhodiola Pharmaceutical Holding Co
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
|
Cash from Investing Activities
-¥831.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-126%
|
CAGR 10-Years
-39%
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Cash from Investing Activities
-¥2.8B
|
CAGR 3-Years
14%
|
CAGR 5-Years
11%
|
CAGR 10-Years
1%
|
|
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Cash from Investing Activities
-¥2.5B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
20%
|
CAGR 10-Years
-11%
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Cash from Investing Activities
-¥1.5B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
7%
|
CAGR 10-Years
-11%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Cash from Investing Activities
-¥129.3m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-1%
|
Huadong Medicine Co Ltd
SZSE:000963
|
Cash from Investing Activities
-¥1.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
13%
|
CAGR 10-Years
-17%
|
See Also
What is Tibet Rhodiola Pharmaceutical Holding Co's Cash from Investing Activities?
Cash from Investing Activities
-831.9m
CNY
Based on the financial report for Dec 31, 2023, Tibet Rhodiola Pharmaceutical Holding Co's Cash from Investing Activities amounts to -831.9m CNY.
What is Tibet Rhodiola Pharmaceutical Holding Co's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-39%
Over the last year, the Cash from Investing Activities growth was -48%.